iRhythm Technologies, Inc. (IRTC)
| Market Cap | 3.96B |
| Revenue (ttm) | 340.89M |
| Net Income (ttm) | -124.19M |
| Shares Out | 29.79M |
| EPS (ttm) | -3.46 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 234,409 |
| Open | 139.33 |
| Previous Close | 139.04 |
| Day's Range | 132.23 - 142.15 |
| 52-Week Range | 41.66 - 169.54 |
| Beta | 1.12 |
| Analysts | Buy |
| Price Target | 178.37 (+34.1%) |
| Earnings Date | May 5, 2022 |
About IRTC
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and E...
Financial Performance
In 2021, IRTC's revenue was $322.83 million, an increase of 21.74% compared to the previous year's $265.17 million. Losses were -$101.36 million, 131.3% more than in 2020.
Financial StatementsAnalyst Forecast
According to 16 analysts, the average rating for IRTC stock is "Buy." The 12-month stock price forecast is 178.37, which is an increase of 34.11% from the latest price.
News
Why iRhythm Technologies jumped 20%
iRhythm Technologies Inc. (NASDAQ: IRTC) was up 20% after the digital healthcare solutions firm focusing on cardiac care advancement announced its financial results for the quarter ending March 31, 2022...
Why Highly Rated iRhythm Technologies Is Making A 20% Jump Today
iRhythm Technologies won a pair of lucrative reimbursement codes from Medicare, leading IRTC stock to rocket early Friday. The post Why Highly Rated iRhythm Technologies Is Making A 20% Jump Today appea...
Investors Cheer Revised, Better Than Expected iRhythm's FY22 Outlook
iRhythm Technologies Inc (NASDAQ: IRTC) posted Q1 sales of $92.4 million, up 24.3% Y/Y, beating the consensus of $86.76 million. The developer of remote external electrocardiogram monitors reported an a...
IRhythm Technologies (IRTC) Reports Q1 Loss, Tops Revenue Estimates
iRhythm Technologies (IRTC) delivered earnings and revenue surprises of 24.53% and 5.97%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
IRhythm Technologies (IRTC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
IRhythm Technologies (IRTC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
iRhythm Technologies to Report First Quarter 2022 Financial Results on May 5, 2022
SAN FRANCISCO, April 21, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced t...
Missed Intuitive Surgical? Buy This Stock Instead
Much as Intuitive Surgical redefined the surgical field, this company is updating how abnormal heart rhythms are diagnosed.
Zio® by iRhythm Shown to Prevent Hospital Admissions, Aid in Early Detection of AF
SAN FRANCISCO, April 03, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, announces the resul...
iRhythm Technologies Announces Amendment to Term Loan Agreement
Provides enhanced credit facility up to $100 million with favorable terms and facility maturity extended to March 2027 Provides enhanced credit facility up to $100 million with favorable terms and facil...
iRhythm Technologies (IRTC) Soars 4.3%: Is Further Upside Left in the Stock?
iRhythm Technologies (IRTC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the nea...
iRhythm® Technologies Announces Kevin King to Retire from Board of Directors
SAN FRANCISCO, March 14, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”), a leading digital healthcare solutions company focused on the advancement of cardiac care, today ...
iRhythm Technologies (IRTC) Upgraded to Buy: What Does It Mean for the Stock?
iRhythm Technologies (IRTC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zio® by iRhythm Shows Significantly Higher Documentation of Atrial Fibrillation and Atrial Flutter Compared to Holter...
Additional clinical research shows bradyarrhythmias can be detected with 14-day cardiac monitoring through Zio XT before and after TAVR Additional clinical research shows bradyarrhythmias can be detecte...
IRhythm Technologies (IRTC) Reports Q4 Loss, Tops Revenue Estimates
iRhythm Technologies (IRTC) delivered earnings and revenue surprises of 9.84% and 4.61%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
iRhythm Technologies Announces Fourth Quarter and Full Year 2021 Financial Results
SAN FRANCISCO, Feb. 23, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today reported fina...
iRhythm Technologies to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022
SAN FRANCISCO, Feb. 09, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced th...
Will IRhythm Technologies Stock Continue To See Higher Levels After A 20% Rally In A Month?
The stock price of iRhythm Technologies, a healthcare company that provides ambulatory electrocardiogram and cardiac monitoring products, has seen a rise of 20% over the last one month (twenty-one tradi...
Strength Seen in iRhythm Technologies (IRTC): Can Its 27.6% Jump Turn into More Strength?
iRhythm Technologies (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength d...
iRhythm Technologies Comments on Medicare Administrative Contractor 2022 Rate Update
SAN FRANCISCO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, commented on the r...
IRTC Stock: 17 Things to Know About iRhythm as Shares Rocket Higher Today
Irhythm Technologies (IRTC) stock is rising higher Monday alongside heavy trading of the shares and we know what's behind that movement! The post IRTC Stock: 17 Things to Know About iRhythm as Shares Ro...
iRhythm® Technologies to Present at the 40th Annual J.P. Morgan Healthcare Conference
SAN FRANCISCO, Dec. 29, 2021 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced the...
IRhythm Stock Falls On Lowered Sales Guidance
Wearable electrocardiograph patch maker IRhythm Technologies Inc's (NASDAQ: IRTC) lowered its revenue guidance for 2021 due to unforeseen impacts related to the COVID-19 Delta variant, customer staffing...
IRhythm Technologies (IRTC) Reports Q3 Loss, Tops Revenue Estimates
iRhythm Technologies (IRTC) delivered earnings and revenue surprises of 25.69% and 2.27%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Why iRhythm Technologies Stock Skyrocketed Today
Investors think that new Medicare payment guidelines will benefit the company.
Why Are iRhythm Shares Soaring Today?
iRhythm Technologies Inc (NASDAQ: IRTC) commented on the CMS (Centers for Medicare and Medicaid Services) Calendar Year 2022 Medicare Physician Fee Schedule (MPFS) Final Rule. In the Final Rule, CMS did...